Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9875389rdf:typepubmed:Citationlld:pubmed
pubmed-article:9875389lifeskim:mentionsumls-concept:C0019369lld:lifeskim
pubmed-article:9875389lifeskim:mentionsumls-concept:C0003451lld:lifeskim
pubmed-article:9875389lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9875389lifeskim:mentionsumls-concept:C0005248lld:lifeskim
pubmed-article:9875389pubmed:issue2lld:pubmed
pubmed-article:9875389pubmed:dateCreated1999-2-2lld:pubmed
pubmed-article:9875389pubmed:abstractTextThe spread of sexually transmitted diseases, including human immunodeficiency virus type 1 (HIV-1) and herpesvirus infections, has continued unabated despite educational efforts spearheaded as a response to the HIV-1 epidemic. This suggests the need for prophylactic measures, including the application of topical antiviral agents. Chemical modification of bovine beta-lactoglobulin (beta-LG), the major protein of whey, by hydroxyphthalic anhydride (3HP) led to the generation of a potent HIV-1 inhibitor (designated 3HP-beta-LG) shown to also have activity against herpes simplex virus types 1 and 2 (HSV-1, HSV-2). This report provides more detailed results concerning the anti-herpesvirus activity of 3HP-beta-LG, indicating that this compound: (i) inhibited infection by human cytomegalovirus (HCMV), which is known to be sexually transmitted; (ii) inactivated the infectivity of both HSV-1 and HSV-2; (iii) inhibited cell-to-cell transmission of HSV-1 and HSV-2; and (iv) bound to HSV-1, HSV-2 and HCMV virus particles and partially inhibited the binding of anti-glycoprotein E (gE) and anti-gC monoclonal antibodies to HSV-1 and HSV-2. The binding of 3HP-beta-LG to the herpesviruses under study was inhibited by aggregated human IgG, suggesting that the respective viral Fc receptor is one of the target sites for 3HP-beta-LG. In agreement with results on inhibition of HIV-1 infection, 3HP-beta-LG appears to be the acid anhydride-modified protein of choice as an antiviral agent against herpesviruses.lld:pubmed
pubmed-article:9875389pubmed:languageenglld:pubmed
pubmed-article:9875389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875389pubmed:citationSubsetIMlld:pubmed
pubmed-article:9875389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9875389pubmed:statusMEDLINElld:pubmed
pubmed-article:9875389pubmed:monthMarlld:pubmed
pubmed-article:9875389pubmed:issn0956-3202lld:pubmed
pubmed-article:9875389pubmed:authorpubmed-author:NeurathA RARlld:pubmed
pubmed-article:9875389pubmed:authorpubmed-author:StrickNNlld:pubmed
pubmed-article:9875389pubmed:authorpubmed-author:LiY YYYlld:pubmed
pubmed-article:9875389pubmed:issnTypePrintlld:pubmed
pubmed-article:9875389pubmed:volume9lld:pubmed
pubmed-article:9875389pubmed:ownerNLMlld:pubmed
pubmed-article:9875389pubmed:authorsCompleteYlld:pubmed
pubmed-article:9875389pubmed:pagination177-84lld:pubmed
pubmed-article:9875389pubmed:dateRevised2005-11-17lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:meshHeadingpubmed-meshheading:9875389-...lld:pubmed
pubmed-article:9875389pubmed:year1998lld:pubmed
pubmed-article:9875389pubmed:articleTitle3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses.lld:pubmed
pubmed-article:9875389pubmed:affiliationLindsley F Kimball Research Institute of the New York Blood Center, New York, NY 10021, USA.lld:pubmed
pubmed-article:9875389pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9875389lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9875389lld:pubmed